CIK: 0001839209 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $654,588 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | 7,697,762 | $454,553 | 69.4% | $40.23 | 0.0% | COM | 717081103 |
| NTLA | INTELLIA THERAPEUTICS INC | 605,587 | $71,605 | 10.9% | $77.87 | +60.9% | COM | 45826J105 |
| AZN | ASTRAZENECA PLC | 511,908 | $29,819 | 4.6% | $58.25 | — | SPONSORED ADR | 046353108 |
| — | INHIBRX INC | 591,975 | $25,852 | 3.9% | $32.14 | — | COM | 45720L107 |
| BNTX | BIONTECH SE | 90,057 | $23,217 | 3.5% | $272.99 | — | SPONSORED ADS | 09075V102 |
| ENTA | ENANTA PHARMACEUTICALS INC | 166,190 | $12,428 | 1.9% | $78.47 | 0.0% | COM | 29251M106 |
| FATE | FATE THERAPEUTICS INC | 153,537 | $8,983 | 1.4% | $72.67 | -22.0% | COM | 31189P102 |
| KROS | KEROS THERAPEUTICS INC | 111,500 | $6,524 | 1.0% | $49.87 | 0.0% | COM | 492327101 |
| VIR | VIR BIOTECHNOLOGY INC | 145,841 | $6,106 | 0.9% | $40.46 | -3.2% | COM | 92764N102 |
| — | CHEMOCENTRYX INC | 161,802 | $5,891 | 0.9% | $36.41 | — | COM | 16383L106 |
| FULC | FULCRUM THERAPEUTICS INC | 317,428 | $5,615 | 0.9% | $19.72 | +0.5% | COM | 359616109 |
| ACRS | ACLARIS THERAPEUTICS INC | 216,143 | $3,143 | 0.5% | $20.73 | -26.9% | COM | 00461U105 |
| — | VERVE THERAPEUTICS INC | 23,104 | $852 | 0.1% | $60.25 | — | COM | 92539P101 |